Sarepta Therapeutics | Myyntikate Myyntiin


Gross Profit On Sales Muuttaa
Acadia Pharmaceuticals ACAD:US $ 104M 19M
Alexion Pharmaceuticals ALXN:US $ 1299.7M 33.4M
Alnylam Pharmaceuticals ALNY:US $ 104.06M 20.02M
Amgen AMGN:US $ 4718M 70M
Biocryst Pharmaceuticals BCRX:US $ 2M 2M
Biogen BIIB:US $ 2927M 343.5M
Biomarin Pharmaceutical BMRN:US $ 331.52M 59.18M
Bluebird Bio BLUE:US $ 19.73M 17.65M
Daiichi Sankyo 4568:JP Y 154736M 16901M
Eli Lilly And LLY:US $ 4277.4M 367.3M
Esperion Therapeutics ESPR:US $ 21.18M 21M
Gilead Sciences GILD:US $ 4079M 500M
Gw Pharmaceuticals GWPH:US $ 129.42M 16.83M
Insmed INSM:US $ 3.25M 412.3K
Intercept Pharmaceuticals ICPT:US $ 75.37M 3.57M
IONIS PHARMACEUT IONS:US $ 142M 12M
Neurocrine Biosciences NBIX:US $ 300M 65M
Pfizer PFE:US $ 9569M 113M
Ptc Therapeutics PTCT:US $ 69.94M 5.76M
Regeneron Pharmaceuticals REGN:US $ 1676.5M 65.6M
Sarepta Therapeutics SRPT:US $ 124M 23M
Ultragenyx Pharmaceutical RARE:US $ 59.91M 20.09M
Vertex Pharmaceuticals VRTX:US $ 1339.96M 12.64M
YTE INCY:US $ 660.08M 113.49M



Sarepta Therapeutics Myyntikate Myyntiin - Käyvät arvot, historialliset tiedot, ennusteita, tilastoja, kaavioita ja taloudellinen kalenteri - Jan 2021.